Page last updated: 2024-09-02

7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride and Fibrosarcoma

7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride has been researched along with Fibrosarcoma in 1 studies

*Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, HJ; Hong, JY; Kim, SH; Kim, WB; Lee, SK; Min, HY; Park, EJ; Park, HJ1

Other Studies

1 other study(ies) available for 7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride and Fibrosarcoma

ArticleYear
Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases.
    Biochemical pharmacology, 2005, Dec-19, Volume: 71, Issue:1-2

    Topics: Anthracyclines; Antineoplastic Agents; Base Sequence; Cell Line, Tumor; DNA Primers; Down-Regulation; Doxorubicin; Electrophoretic Mobility Shift Assay; Fibrosarcoma; Humans; Matrix Metalloproteinases; Neoplasm Invasiveness; NF-kappa B; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic

2005